[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"conditionNormalized\":\"alternative-surgical-treatment-for-aortic-valve-disease\",\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:alternative-surgical-treatment-for-aortic-valve-disease":45},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,1,0,[8],{"id":9,"slug":4,"hasResults":10,"nctId":11,"briefTitle":12,"officialTitle":13,"acronym":14,"eligibilityCriteria":15,"healthyVolunteers":10,"sex":16,"minAge":17,"maxAge":4,"enrollmentInfo":18,"targetDuration":4,"studyType":21,"phases":22,"briefSummary":24,"conditions":25,"keywords":27,"overallStatus":33,"whyStopped":4,"lastUpdateSubmitDate":34,"lastUpdatePostDateStruct":35,"startDateStruct":38,"completionDateStruct":40,"leadSponsor":42,"locationsCount":5},"100331853",false,"NCT03600662","TriRec - Trileaflet Reconstruction of the Aortic Valve With Autologous Pericardium","TriRec - Trileaflet Reconstruction of the Aortic Valve","TriRec","Inclusion Criteria:\n\n* Age \\>= 50 years\n* Documented symptomatic moderate or greater aortic stenosis or severe insufficiency\n* Aortic annulus \\> 19 mm\n* Written informed consent of the patient.\n\nExclusion Criteria:\n\n* Concomitant intervention of the aortic root\n* Concomitant intervention of the aortic arch\n* Concomitant valve surgery\n* Emergency surgery for any reason\n* Neurological events (i.e. stroke, TIA) within 6 months preoperatively\n* Coagulation disorders (including thrombocytopenia \\\u003C 100.000\u002Fml)\n* Porcelain aorta\n* Active endocarditis or other active systemic infections\n* Participating in another trial that may influence the outcome of this trial\n* Pregnancy\n* Dual antiplatelet therapy\n* Previous cardiac surgery (excluding percutaneous procedures)","ALL","50 Years",{"count":19,"type":20},128,"ESTIMATED","INTERVENTIONAL",[23],"NA","Reconstruction of the aortic valve using the tri-leaflet repair technique is non-inferior with regard to effective orifice area (EOA) to surgical aortic valve replacement (SAVR) with a biological prosthesis (St. Jude Trifecta GT) as gold- standard.",[26],"Alternative Surgical Treatment for Aortic Valve Disease",[28,29,30,31,32],"aortic stenosis","aortic regurgitation","Trileaflet reconstruction of the aortic valve","Biological aortic valve prosthesis","Effective orifice area","RECRUITING","2018-07-16",{"date":36,"type":37},"2018-07-26","ACTUAL",{"date":39,"type":37},"2018-01-18",{"date":41,"type":20},"2030-01",{"name":43,"class":44},"Deutsches Herzzentrum Muenchen","OTHER",""]